nodes	percent_of_prediction	percent_of_DWPC	metapath
Felodipine—ABCB1—ovarian cancer	0.204	1	CbGaD
Felodipine—CYP3A7-CYP3A51P—Paclitaxel—ovarian cancer	0.0342	0.0883	CbGbCtD
Felodipine—CYP3A7—Paclitaxel—ovarian cancer	0.0342	0.0883	CbGbCtD
Felodipine—ABCB1—Topotecan—ovarian cancer	0.0337	0.0871	CbGbCtD
Felodipine—CYP3A5—Paclitaxel—ovarian cancer	0.0257	0.0663	CbGbCtD
Felodipine—CYP3A7-CYP3A51P—Docetaxel—ovarian cancer	0.0247	0.0639	CbGbCtD
Felodipine—CYP3A7—Docetaxel—ovarian cancer	0.0247	0.0639	CbGbCtD
Felodipine—CYP2C8—Paclitaxel—ovarian cancer	0.0247	0.0637	CbGbCtD
Felodipine—ABCB1—Vinorelbine—ovarian cancer	0.0238	0.0614	CbGbCtD
Felodipine—CYP2D6—Vinorelbine—ovarian cancer	0.0224	0.0578	CbGbCtD
Felodipine—CYP3A4—Topotecan—ovarian cancer	0.0202	0.0522	CbGbCtD
Felodipine—CYP3A5—Docetaxel—ovarian cancer	0.0185	0.0479	CbGbCtD
Felodipine—CYP2C9—Paclitaxel—ovarian cancer	0.0172	0.0444	CbGbCtD
Felodipine—ABCB1—Paclitaxel—ovarian cancer	0.0167	0.0431	CbGbCtD
Felodipine—CYP3A4—Vinorelbine—ovarian cancer	0.0142	0.0368	CbGbCtD
Felodipine—ABCB1—Docetaxel—ovarian cancer	0.0121	0.0312	CbGbCtD
Felodipine—CYP3A4—Paclitaxel—ovarian cancer	0.01	0.0258	CbGbCtD
Felodipine—ABCB1—Doxorubicin—ovarian cancer	0.009	0.0232	CbGbCtD
Felodipine—CYP2D6—Doxorubicin—ovarian cancer	0.00848	0.0219	CbGbCtD
Felodipine—CYP3A4—Docetaxel—ovarian cancer	0.00723	0.0187	CbGbCtD
Felodipine—CYP3A4—Doxorubicin—ovarian cancer	0.00539	0.0139	CbGbCtD
Felodipine—CALM2—oviduct—ovarian cancer	0.0034	0.0308	CbGeAlD
Felodipine—TNNC2—female gonad—ovarian cancer	0.00335	0.0304	CbGeAlD
Felodipine—TNNC2—testis—ovarian cancer	0.00297	0.0269	CbGeAlD
Felodipine—TNNC1—endometrium—ovarian cancer	0.00224	0.0203	CbGeAlD
Felodipine—CACNA1H—myometrium—ovarian cancer	0.00217	0.0197	CbGeAlD
Felodipine—PDE1B—gonad—ovarian cancer	0.00217	0.0196	CbGeAlD
Felodipine—PDE1A—uterine cervix—ovarian cancer	0.00216	0.0196	CbGeAlD
Felodipine—TNNC2—lymph node—ovarian cancer	0.00215	0.0195	CbGeAlD
Felodipine—PDE1B—female reproductive system—ovarian cancer	0.00193	0.0175	CbGeAlD
Felodipine—PDE1A—gonad—ovarian cancer	0.00181	0.0165	CbGeAlD
Felodipine—PDE1A—uterus—ovarian cancer	0.0018	0.0164	CbGeAlD
Felodipine—CACNA1C—myometrium—ovarian cancer	0.00165	0.015	CbGeAlD
Felodipine—PDE1A—female reproductive system—ovarian cancer	0.00162	0.0147	CbGeAlD
Felodipine—PDE1B—testis—ovarian cancer	0.00156	0.0142	CbGeAlD
Felodipine—NR3C2—myometrium—ovarian cancer	0.0015	0.0137	CbGeAlD
Felodipine—TNNC1—testis—ovarian cancer	0.0015	0.0136	CbGeAlD
Felodipine—PDE1A—female gonad—ovarian cancer	0.00147	0.0134	CbGeAlD
Felodipine—CACNA1H—gonad—ovarian cancer	0.00142	0.0128	CbGeAlD
Felodipine—CACNA2D2—vagina—ovarian cancer	0.00141	0.0128	CbGeAlD
Felodipine—CACNA1H—uterus—ovarian cancer	0.00141	0.0128	CbGeAlD
Felodipine—CACNA1D—uterine cervix—ovarian cancer	0.00139	0.0126	CbGeAlD
Felodipine—CALM3—myometrium—ovarian cancer	0.00138	0.0126	CbGeAlD
Felodipine—PDE1A—testis—ovarian cancer	0.00131	0.0119	CbGeAlD
Felodipine—CACNA1H—female reproductive system—ovarian cancer	0.00127	0.0115	CbGeAlD
Felodipine—CACNA2D2—testis—ovarian cancer	0.00126	0.0114	CbGeAlD
Felodipine—CACNA1C—decidua—ovarian cancer	0.00123	0.0111	CbGeAlD
Felodipine—NR3C2—uterine cervix—ovarian cancer	0.00117	0.0106	CbGeAlD
Felodipine—CACNA1H—female gonad—ovarian cancer	0.00115	0.0104	CbGeAlD
Felodipine—PDE1B—lymph node—ovarian cancer	0.00113	0.0103	CbGeAlD
Felodipine—CALM2—myometrium—ovarian cancer	0.00109	0.00986	CbGeAlD
Felodipine—TNNC1—lymph node—ovarian cancer	0.00108	0.00984	CbGeAlD
Felodipine—CALM1—myometrium—ovarian cancer	0.00108	0.00982	CbGeAlD
Felodipine—CACNB2—vagina—ovarian cancer	0.00108	0.0098	CbGeAlD
Felodipine—CALM3—uterine cervix—ovarian cancer	0.00108	0.00977	CbGeAlD
Felodipine—CACNA2D1—bone marrow—ovarian cancer	0.00106	0.00961	CbGeAlD
Felodipine—NR3C2—endometrium—ovarian cancer	0.00106	0.00961	CbGeAlD
Felodipine—CALM2—embryo—ovarian cancer	0.00105	0.00949	CbGeAlD
Felodipine—CALM1—embryo—ovarian cancer	0.00104	0.00944	CbGeAlD
Felodipine—CALM3—decidua—ovarian cancer	0.00103	0.00931	CbGeAlD
Felodipine—CACNA1H—testis—ovarian cancer	0.00102	0.00926	CbGeAlD
Felodipine—CACNA2D1—female gonad—ovarian cancer	0.00102	0.00926	CbGeAlD
Felodipine—CACNA2D1—vagina—ovarian cancer	0.00101	0.0092	CbGeAlD
Felodipine—NR3C2—uterus—ovarian cancer	0.000976	0.00885	CbGeAlD
Felodipine—CALM3—endometrium—ovarian cancer	0.000975	0.00884	CbGeAlD
Felodipine—CACNB2—testis—ovarian cancer	0.000964	0.00875	CbGeAlD
Felodipine—CACNA1C—female reproductive system—ovarian cancer	0.000964	0.00874	CbGeAlD
Felodipine—PDE1A—lymph node—ovarian cancer	0.000948	0.0086	CbGeAlD
Felodipine—CACNA2D2—lymph node—ovarian cancer	0.000913	0.00828	CbGeAlD
Felodipine—CACNA2D1—testis—ovarian cancer	0.000905	0.00821	CbGeAlD
Felodipine—CALM3—uterus—ovarian cancer	0.000898	0.00815	CbGeAlD
Felodipine—NR3C2—female reproductive system—ovarian cancer	0.000877	0.00796	CbGeAlD
Felodipine—CACNA1C—vagina—ovarian cancer	0.000872	0.00791	CbGeAlD
Felodipine—CALM2—epithelium—ovarian cancer	0.000854	0.00774	CbGeAlD
Felodipine—CALM1—epithelium—ovarian cancer	0.00085	0.00771	CbGeAlD
Felodipine—CALM2—uterine cervix—ovarian cancer	0.000846	0.00768	CbGeAlD
Felodipine—CACNA1D—testis—ovarian cancer	0.000843	0.00764	CbGeAlD
Felodipine—CALM1—uterine cervix—ovarian cancer	0.000842	0.00764	CbGeAlD
Felodipine—CALM2—decidua—ovarian cancer	0.000806	0.00731	CbGeAlD
Felodipine—CALM1—decidua—ovarian cancer	0.000803	0.00728	CbGeAlD
Felodipine—NR3C2—female gonad—ovarian cancer	0.000798	0.00724	CbGeAlD
Felodipine—NR3C2—vagina—ovarian cancer	0.000794	0.0072	CbGeAlD
Felodipine—CACNA1C—testis—ovarian cancer	0.000778	0.00706	CbGeAlD
Felodipine—CALM2—endometrium—ovarian cancer	0.000765	0.00694	CbGeAlD
Felodipine—CALM3—bone marrow—ovarian cancer	0.000762	0.00691	CbGeAlD
Felodipine—CALM1—endometrium—ovarian cancer	0.000762	0.00691	CbGeAlD
Felodipine—CACNA1H—lymph node—ovarian cancer	0.00074	0.00671	CbGeAlD
Felodipine—CALM3—female gonad—ovarian cancer	0.000735	0.00666	CbGeAlD
Felodipine—CALM3—vagina—ovarian cancer	0.00073	0.00662	CbGeAlD
Felodipine—CALM2—gonad—ovarian cancer	0.00071	0.00644	CbGeAlD
Felodipine—NR3C2—testis—ovarian cancer	0.000708	0.00642	CbGeAlD
Felodipine—CALM1—gonad—ovarian cancer	0.000707	0.00641	CbGeAlD
Felodipine—CALM2—uterus—ovarian cancer	0.000705	0.0064	CbGeAlD
Felodipine—CALM1—uterus—ovarian cancer	0.000702	0.00637	CbGeAlD
Felodipine—CACNB2—lymph node—ovarian cancer	0.000699	0.00634	CbGeAlD
Felodipine—CACNA2D1—lymph node—ovarian cancer	0.000656	0.00595	CbGeAlD
Felodipine—CALM3—testis—ovarian cancer	0.000652	0.00591	CbGeAlD
Felodipine—CYP2C8—endometrium—ovarian cancer	0.000634	0.00575	CbGeAlD
Felodipine—CALM2—female reproductive system—ovarian cancer	0.000634	0.00575	CbGeAlD
Felodipine—CYP3A5—uterine cervix—ovarian cancer	0.000633	0.00574	CbGeAlD
Felodipine—CALM1—female reproductive system—ovarian cancer	0.000631	0.00572	CbGeAlD
Felodipine—CACNA1D—lymph node—ovarian cancer	0.000611	0.00554	CbGeAlD
Felodipine—CALM2—bone marrow—ovarian cancer	0.000599	0.00543	CbGeAlD
Felodipine—CALM1—bone marrow—ovarian cancer	0.000596	0.0054	CbGeAlD
Felodipine—CALM2—female gonad—ovarian cancer	0.000577	0.00523	CbGeAlD
Felodipine—CALM1—female gonad—ovarian cancer	0.000574	0.00521	CbGeAlD
Felodipine—CALM2—vagina—ovarian cancer	0.000573	0.0052	CbGeAlD
Felodipine—CALM1—vagina—ovarian cancer	0.000571	0.00518	CbGeAlD
Felodipine—CACNA1C—lymph node—ovarian cancer	0.000564	0.00512	CbGeAlD
Felodipine—CYP2C8—female reproductive system—ovarian cancer	0.000526	0.00477	CbGeAlD
Felodipine—NR3C2—lymph node—ovarian cancer	0.000513	0.00466	CbGeAlD
Felodipine—CALM2—testis—ovarian cancer	0.000512	0.00464	CbGeAlD
Felodipine—CALM1—testis—ovarian cancer	0.000509	0.00462	CbGeAlD
Felodipine—CYP2C8—vagina—ovarian cancer	0.000475	0.00431	CbGeAlD
Felodipine—CALM3—lymph node—ovarian cancer	0.000472	0.00428	CbGeAlD
Felodipine—CYP2C9—female reproductive system—ovarian cancer	0.000467	0.00423	CbGeAlD
Felodipine—ABCB1—myometrium—ovarian cancer	0.000432	0.00392	CbGeAlD
Felodipine—CYP3A5—female gonad—ovarian cancer	0.000432	0.00391	CbGeAlD
Felodipine—CYP3A5—vagina—ovarian cancer	0.000429	0.00389	CbGeAlD
Felodipine—CYP2C8—testis—ovarian cancer	0.000424	0.00385	CbGeAlD
Felodipine—ABCB1—embryo—ovarian cancer	0.000416	0.00377	CbGeAlD
Felodipine—CALM2—lymph node—ovarian cancer	0.000371	0.00336	CbGeAlD
Felodipine—CALM1—lymph node—ovarian cancer	0.000369	0.00335	CbGeAlD
Felodipine—CYP3A4—female reproductive system—ovarian cancer	0.000356	0.00323	CbGeAlD
Felodipine—CYP2D6—female reproductive system—ovarian cancer	0.00035	0.00318	CbGeAlD
Felodipine—ABCB1—epithelium—ovarian cancer	0.000339	0.00308	CbGeAlD
Felodipine—ABCB1—uterine cervix—ovarian cancer	0.000336	0.00305	CbGeAlD
Felodipine—Constipation—Vinorelbine—ovarian cancer	0.000323	0.00251	CcSEcCtD
Felodipine—ABCB1—decidua—ovarian cancer	0.00032	0.00291	CbGeAlD
Felodipine—Arrhythmia—Paclitaxel—ovarian cancer	0.000319	0.00248	CcSEcCtD
Felodipine—CYP2D6—female gonad—ovarian cancer	0.000319	0.00289	CbGeAlD
Felodipine—Hypersensitivity—Melphalan—ovarian cancer	0.000318	0.00248	CcSEcCtD
Felodipine—Epistaxis—Docetaxel—ovarian cancer	0.000318	0.00248	CcSEcCtD
Felodipine—Asthenia—Topotecan—ovarian cancer	0.000316	0.00246	CcSEcCtD
Felodipine—Vomiting—Chlorambucil—ovarian cancer	0.000315	0.00245	CcSEcCtD
Felodipine—Pruritus—Topotecan—ovarian cancer	0.000312	0.00243	CcSEcCtD
Felodipine—Erythema—Paclitaxel—ovarian cancer	0.000311	0.00242	CcSEcCtD
Felodipine—Feeling abnormal—Vinorelbine—ovarian cancer	0.000311	0.00242	CcSEcCtD
Felodipine—Asthenia—Melphalan—ovarian cancer	0.00031	0.00241	CcSEcCtD
Felodipine—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.000308	0.0024	CcSEcCtD
Felodipine—Flatulence—Paclitaxel—ovarian cancer	0.000306	0.00239	CcSEcCtD
Felodipine—Pruritus—Melphalan—ovarian cancer	0.000305	0.00238	CcSEcCtD
Felodipine—Tension—Paclitaxel—ovarian cancer	0.000305	0.00238	CcSEcCtD
Felodipine—ABCB1—endometrium—ovarian cancer	0.000304	0.00276	CbGeAlD
Felodipine—Nervousness—Paclitaxel—ovarian cancer	0.000302	0.00235	CcSEcCtD
Felodipine—Diarrhoea—Topotecan—ovarian cancer	0.000302	0.00235	CcSEcCtD
Felodipine—Cerebrovascular accident—Epirubicin—ovarian cancer	0.000301	0.00235	CcSEcCtD
Felodipine—Back pain—Paclitaxel—ovarian cancer	0.000301	0.00234	CcSEcCtD
Felodipine—Pharyngitis—Docetaxel—ovarian cancer	0.0003	0.00234	CcSEcCtD
Felodipine—Urticaria—Vinorelbine—ovarian cancer	0.0003	0.00233	CcSEcCtD
Felodipine—Muscle spasms—Paclitaxel—ovarian cancer	0.000299	0.00233	CcSEcCtD
Felodipine—Body temperature increased—Vinorelbine—ovarian cancer	0.000298	0.00232	CcSEcCtD
Felodipine—Abdominal pain—Vinorelbine—ovarian cancer	0.000298	0.00232	CcSEcCtD
Felodipine—Oedema peripheral—Docetaxel—ovarian cancer	0.000298	0.00232	CcSEcCtD
Felodipine—Diarrhoea—Melphalan—ovarian cancer	0.000295	0.0023	CcSEcCtD
Felodipine—Pain in extremity—Epirubicin—ovarian cancer	0.000295	0.0023	CcSEcCtD
Felodipine—Nausea—Chlorambucil—ovarian cancer	0.000294	0.00229	CcSEcCtD
Felodipine—Visual impairment—Docetaxel—ovarian cancer	0.000292	0.00227	CcSEcCtD
Felodipine—Dizziness—Topotecan—ovarian cancer	0.000292	0.00227	CcSEcCtD
Felodipine—Tremor—Paclitaxel—ovarian cancer	0.000291	0.00227	CcSEcCtD
Felodipine—Anaemia—Paclitaxel—ovarian cancer	0.000287	0.00224	CcSEcCtD
Felodipine—Erythema multiforme—Docetaxel—ovarian cancer	0.000286	0.00223	CcSEcCtD
Felodipine—Face oedema—Epirubicin—ovarian cancer	0.000285	0.00222	CcSEcCtD
Felodipine—Angioedema—Paclitaxel—ovarian cancer	0.000284	0.00221	CcSEcCtD
Felodipine—CYP2D6—testis—ovarian cancer	0.000283	0.00256	CbGeAlD
Felodipine—ABCB1—gonad—ovarian cancer	0.000282	0.00256	CbGeAlD
Felodipine—Flushing—Docetaxel—ovarian cancer	0.000281	0.00219	CcSEcCtD
Felodipine—Vomiting—Topotecan—ovarian cancer	0.00028	0.00218	CcSEcCtD
Felodipine—ABCB1—uterus—ovarian cancer	0.00028	0.00254	CbGeAlD
Felodipine—Vertigo—Paclitaxel—ovarian cancer	0.000279	0.00218	CcSEcCtD
Felodipine—Syncope—Paclitaxel—ovarian cancer	0.000279	0.00217	CcSEcCtD
Felodipine—Cerebrovascular accident—Doxorubicin—ovarian cancer	0.000279	0.00217	CcSEcCtD
Felodipine—Rash—Topotecan—ovarian cancer	0.000278	0.00217	CcSEcCtD
Felodipine—Hypersensitivity—Vinorelbine—ovarian cancer	0.000278	0.00216	CcSEcCtD
Felodipine—Dermatitis—Topotecan—ovarian cancer	0.000278	0.00216	CcSEcCtD
Felodipine—Headache—Topotecan—ovarian cancer	0.000276	0.00215	CcSEcCtD
Felodipine—Palpitations—Paclitaxel—ovarian cancer	0.000275	0.00214	CcSEcCtD
Felodipine—Vomiting—Melphalan—ovarian cancer	0.000274	0.00214	CcSEcCtD
Felodipine—Loss of consciousness—Paclitaxel—ovarian cancer	0.000273	0.00213	CcSEcCtD
Felodipine—Pain in extremity—Doxorubicin—ovarian cancer	0.000273	0.00213	CcSEcCtD
Felodipine—Rash—Melphalan—ovarian cancer	0.000272	0.00212	CcSEcCtD
Felodipine—Dermatitis—Melphalan—ovarian cancer	0.000272	0.00212	CcSEcCtD
Felodipine—Cough—Paclitaxel—ovarian cancer	0.000271	0.00211	CcSEcCtD
Felodipine—Asthenia—Vinorelbine—ovarian cancer	0.000271	0.00211	CcSEcCtD
Felodipine—Arrhythmia—Docetaxel—ovarian cancer	0.00027	0.00211	CcSEcCtD
Felodipine—Orthostatic hypotension—Epirubicin—ovarian cancer	0.00027	0.0021	CcSEcCtD
Felodipine—Pruritus—Vinorelbine—ovarian cancer	0.000267	0.00208	CcSEcCtD
Felodipine—Chest pain—Paclitaxel—ovarian cancer	0.000265	0.00206	CcSEcCtD
Felodipine—Arthralgia—Paclitaxel—ovarian cancer	0.000265	0.00206	CcSEcCtD
Felodipine—Myalgia—Paclitaxel—ovarian cancer	0.000265	0.00206	CcSEcCtD
Felodipine—Nasopharyngitis—Epirubicin—ovarian cancer	0.000264	0.00206	CcSEcCtD
Felodipine—Face oedema—Doxorubicin—ovarian cancer	0.000264	0.00205	CcSEcCtD
Felodipine—Erythema—Docetaxel—ovarian cancer	0.000263	0.00205	CcSEcCtD
Felodipine—Nausea—Topotecan—ovarian cancer	0.000262	0.00204	CcSEcCtD
Felodipine—Dry mouth—Paclitaxel—ovarian cancer	0.000259	0.00202	CcSEcCtD
Felodipine—Diarrhoea—Vinorelbine—ovarian cancer	0.000258	0.00201	CcSEcCtD
Felodipine—Nausea—Melphalan—ovarian cancer	0.000256	0.002	CcSEcCtD
Felodipine—Confusional state—Paclitaxel—ovarian cancer	0.000256	0.00199	CcSEcCtD
Felodipine—Influenza—Epirubicin—ovarian cancer	0.000255	0.00199	CcSEcCtD
Felodipine—Back pain—Docetaxel—ovarian cancer	0.000255	0.00198	CcSEcCtD
Felodipine—Muscle spasms—Docetaxel—ovarian cancer	0.000253	0.00197	CcSEcCtD
Felodipine—ABCB1—female reproductive system—ovarian cancer	0.000252	0.00229	CbGeAlD
Felodipine—Shock—Paclitaxel—ovarian cancer	0.00025	0.00194	CcSEcCtD
Felodipine—Dizziness—Vinorelbine—ovarian cancer	0.000249	0.00194	CcSEcCtD
Felodipine—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.000249	0.00194	CcSEcCtD
Felodipine—Angina pectoris—Epirubicin—ovarian cancer	0.000248	0.00193	CcSEcCtD
Felodipine—Tachycardia—Paclitaxel—ovarian cancer	0.000248	0.00193	CcSEcCtD
Felodipine—Bronchitis—Epirubicin—ovarian cancer	0.000245	0.00191	CcSEcCtD
Felodipine—Nasopharyngitis—Doxorubicin—ovarian cancer	0.000244	0.0019	CcSEcCtD
Felodipine—Anaemia—Docetaxel—ovarian cancer	0.000244	0.0019	CcSEcCtD
Felodipine—Vomiting—Vinorelbine—ovarian cancer	0.00024	0.00187	CcSEcCtD
Felodipine—Dysuria—Epirubicin—ovarian cancer	0.000238	0.00186	CcSEcCtD
Felodipine—ABCB1—bone marrow—ovarian cancer	0.000238	0.00216	CbGeAlD
Felodipine—Rash—Vinorelbine—ovarian cancer	0.000238	0.00185	CcSEcCtD
Felodipine—Dermatitis—Vinorelbine—ovarian cancer	0.000238	0.00185	CcSEcCtD
Felodipine—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.000237	0.00185	CcSEcCtD
Felodipine—Headache—Vinorelbine—ovarian cancer	0.000236	0.00184	CcSEcCtD
Felodipine—Syncope—Docetaxel—ovarian cancer	0.000236	0.00184	CcSEcCtD
Felodipine—Influenza—Doxorubicin—ovarian cancer	0.000236	0.00184	CcSEcCtD
Felodipine—Pollakiuria—Epirubicin—ovarian cancer	0.000236	0.00183	CcSEcCtD
Felodipine—Palpitations—Docetaxel—ovarian cancer	0.000233	0.00181	CcSEcCtD
Felodipine—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000233	0.00181	CcSEcCtD
Felodipine—Loss of consciousness—Docetaxel—ovarian cancer	0.000232	0.0018	CcSEcCtD
Felodipine—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000231	0.0018	CcSEcCtD
Felodipine—Cough—Docetaxel—ovarian cancer	0.00023	0.00179	CcSEcCtD
Felodipine—Angina pectoris—Doxorubicin—ovarian cancer	0.00023	0.00179	CcSEcCtD
Felodipine—Insomnia—Paclitaxel—ovarian cancer	0.000229	0.00179	CcSEcCtD
Felodipine—ABCB1—female gonad—ovarian cancer	0.000229	0.00208	CbGeAlD
Felodipine—ABCB1—vagina—ovarian cancer	0.000228	0.00207	CbGeAlD
Felodipine—Paraesthesia—Paclitaxel—ovarian cancer	0.000228	0.00177	CcSEcCtD
Felodipine—Bronchitis—Doxorubicin—ovarian cancer	0.000227	0.00177	CcSEcCtD
Felodipine—Dyspnoea—Paclitaxel—ovarian cancer	0.000226	0.00176	CcSEcCtD
Felodipine—Somnolence—Paclitaxel—ovarian cancer	0.000226	0.00176	CcSEcCtD
Felodipine—Myalgia—Docetaxel—ovarian cancer	0.000224	0.00175	CcSEcCtD
Felodipine—Chest pain—Docetaxel—ovarian cancer	0.000224	0.00175	CcSEcCtD
Felodipine—Arthralgia—Docetaxel—ovarian cancer	0.000224	0.00175	CcSEcCtD
Felodipine—Nausea—Vinorelbine—ovarian cancer	0.000224	0.00174	CcSEcCtD
Felodipine—Dyspepsia—Paclitaxel—ovarian cancer	0.000223	0.00174	CcSEcCtD
Felodipine—Dysuria—Doxorubicin—ovarian cancer	0.000221	0.00172	CcSEcCtD
Felodipine—Dry mouth—Docetaxel—ovarian cancer	0.000219	0.00171	CcSEcCtD
Felodipine—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000219	0.00171	CcSEcCtD
Felodipine—Fatigue—Paclitaxel—ovarian cancer	0.000219	0.0017	CcSEcCtD
Felodipine—Pollakiuria—Doxorubicin—ovarian cancer	0.000218	0.0017	CcSEcCtD
Felodipine—Constipation—Paclitaxel—ovarian cancer	0.000217	0.00169	CcSEcCtD
Felodipine—Confusional state—Docetaxel—ovarian cancer	0.000217	0.00169	CcSEcCtD
Felodipine—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000215	0.00168	CcSEcCtD
Felodipine—Epistaxis—Epirubicin—ovarian cancer	0.000214	0.00167	CcSEcCtD
Felodipine—Sinusitis—Epirubicin—ovarian cancer	0.000213	0.00166	CcSEcCtD
Felodipine—Shock—Docetaxel—ovarian cancer	0.000212	0.00165	CcSEcCtD
Felodipine—Nisoldipine—ABCB1—ovarian cancer	0.00021	0.24	CrCbGaD
Felodipine—Tachycardia—Docetaxel—ovarian cancer	0.00021	0.00163	CcSEcCtD
Felodipine—Feeling abnormal—Paclitaxel—ovarian cancer	0.000209	0.00163	CcSEcCtD
Felodipine—Bradycardia—Epirubicin—ovarian cancer	0.000208	0.00162	CcSEcCtD
Felodipine—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000207	0.00162	CcSEcCtD
Felodipine—ABCB1—testis—ovarian cancer	0.000203	0.00184	CbGeAlD
Felodipine—Pharyngitis—Epirubicin—ovarian cancer	0.000203	0.00158	CcSEcCtD
Felodipine—Urticaria—Paclitaxel—ovarian cancer	0.000202	0.00157	CcSEcCtD
Felodipine—Oedema peripheral—Epirubicin—ovarian cancer	0.000201	0.00157	CcSEcCtD
Felodipine—Abdominal pain—Paclitaxel—ovarian cancer	0.000201	0.00156	CcSEcCtD
Felodipine—Body temperature increased—Paclitaxel—ovarian cancer	0.000201	0.00156	CcSEcCtD
Felodipine—Epistaxis—Doxorubicin—ovarian cancer	0.000198	0.00155	CcSEcCtD
Felodipine—Sinusitis—Doxorubicin—ovarian cancer	0.000197	0.00154	CcSEcCtD
Felodipine—Visual impairment—Epirubicin—ovarian cancer	0.000197	0.00153	CcSEcCtD
Felodipine—Nitrendipine—ABCB1—ovarian cancer	0.000197	0.224	CrCbGaD
Felodipine—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000196	0.00153	CcSEcCtD
Felodipine—Insomnia—Docetaxel—ovarian cancer	0.000194	0.00151	CcSEcCtD
Felodipine—Paraesthesia—Docetaxel—ovarian cancer	0.000193	0.0015	CcSEcCtD
Felodipine—Erythema multiforme—Epirubicin—ovarian cancer	0.000193	0.0015	CcSEcCtD
Felodipine—Bradycardia—Doxorubicin—ovarian cancer	0.000192	0.0015	CcSEcCtD
Felodipine—Dyspnoea—Docetaxel—ovarian cancer	0.000192	0.00149	CcSEcCtD
Felodipine—Somnolence—Docetaxel—ovarian cancer	0.000191	0.00149	CcSEcCtD
Felodipine—Flushing—Epirubicin—ovarian cancer	0.000189	0.00148	CcSEcCtD
Felodipine—Dyspepsia—Docetaxel—ovarian cancer	0.000189	0.00147	CcSEcCtD
Felodipine—Pharyngitis—Doxorubicin—ovarian cancer	0.000187	0.00146	CcSEcCtD
Felodipine—Hypersensitivity—Paclitaxel—ovarian cancer	0.000187	0.00146	CcSEcCtD
Felodipine—Oedema peripheral—Doxorubicin—ovarian cancer	0.000186	0.00145	CcSEcCtD
Felodipine—Fatigue—Docetaxel—ovarian cancer	0.000185	0.00144	CcSEcCtD
Felodipine—Constipation—Docetaxel—ovarian cancer	0.000184	0.00143	CcSEcCtD
Felodipine—Arrhythmia—Epirubicin—ovarian cancer	0.000182	0.00142	CcSEcCtD
Felodipine—Visual impairment—Doxorubicin—ovarian cancer	0.000182	0.00142	CcSEcCtD
Felodipine—Asthenia—Paclitaxel—ovarian cancer	0.000182	0.00142	CcSEcCtD
Felodipine—Pruritus—Paclitaxel—ovarian cancer	0.000179	0.0014	CcSEcCtD
Felodipine—Erythema multiforme—Doxorubicin—ovarian cancer	0.000179	0.00139	CcSEcCtD
Felodipine—Erythema—Epirubicin—ovarian cancer	0.000178	0.00138	CcSEcCtD
Felodipine—Feeling abnormal—Docetaxel—ovarian cancer	0.000177	0.00138	CcSEcCtD
Felodipine—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000176	0.00137	CcSEcCtD
Felodipine—Flushing—Doxorubicin—ovarian cancer	0.000175	0.00137	CcSEcCtD
Felodipine—Flatulence—Epirubicin—ovarian cancer	0.000175	0.00136	CcSEcCtD
Felodipine—Tension—Epirubicin—ovarian cancer	0.000174	0.00136	CcSEcCtD
Felodipine—Diarrhoea—Paclitaxel—ovarian cancer	0.000174	0.00135	CcSEcCtD
Felodipine—Nervousness—Epirubicin—ovarian cancer	0.000173	0.00134	CcSEcCtD
Felodipine—Back pain—Epirubicin—ovarian cancer	0.000172	0.00134	CcSEcCtD
Felodipine—Muscle spasms—Epirubicin—ovarian cancer	0.000171	0.00133	CcSEcCtD
Felodipine—Body temperature increased—Docetaxel—ovarian cancer	0.00017	0.00132	CcSEcCtD
Felodipine—Abdominal pain—Docetaxel—ovarian cancer	0.00017	0.00132	CcSEcCtD
Felodipine—Amlodipine—ABCB1—ovarian cancer	0.000169	0.193	CrCbGaD
Felodipine—Arrhythmia—Doxorubicin—ovarian cancer	0.000169	0.00131	CcSEcCtD
Felodipine—Dizziness—Paclitaxel—ovarian cancer	0.000168	0.00131	CcSEcCtD
Felodipine—Erythema—Doxorubicin—ovarian cancer	0.000164	0.00128	CcSEcCtD
Felodipine—Anaemia—Epirubicin—ovarian cancer	0.000164	0.00128	CcSEcCtD
Felodipine—Flatulence—Doxorubicin—ovarian cancer	0.000162	0.00126	CcSEcCtD
Felodipine—Tension—Doxorubicin—ovarian cancer	0.000161	0.00126	CcSEcCtD
Felodipine—Vomiting—Paclitaxel—ovarian cancer	0.000161	0.00126	CcSEcCtD
Felodipine—Rash—Paclitaxel—ovarian cancer	0.00016	0.00125	CcSEcCtD
Felodipine—Dermatitis—Paclitaxel—ovarian cancer	0.00016	0.00124	CcSEcCtD
Felodipine—Nervousness—Doxorubicin—ovarian cancer	0.00016	0.00124	CcSEcCtD
Felodipine—Vertigo—Epirubicin—ovarian cancer	0.00016	0.00124	CcSEcCtD
Felodipine—Syncope—Epirubicin—ovarian cancer	0.000159	0.00124	CcSEcCtD
Felodipine—Back pain—Doxorubicin—ovarian cancer	0.000159	0.00124	CcSEcCtD
Felodipine—Headache—Paclitaxel—ovarian cancer	0.000159	0.00124	CcSEcCtD
Felodipine—Hypersensitivity—Docetaxel—ovarian cancer	0.000158	0.00123	CcSEcCtD
Felodipine—Muscle spasms—Doxorubicin—ovarian cancer	0.000158	0.00123	CcSEcCtD
Felodipine—Palpitations—Epirubicin—ovarian cancer	0.000157	0.00122	CcSEcCtD
Felodipine—Loss of consciousness—Epirubicin—ovarian cancer	0.000156	0.00122	CcSEcCtD
Felodipine—Cough—Epirubicin—ovarian cancer	0.000155	0.00121	CcSEcCtD
Felodipine—Asthenia—Docetaxel—ovarian cancer	0.000154	0.0012	CcSEcCtD
Felodipine—Pruritus—Docetaxel—ovarian cancer	0.000152	0.00118	CcSEcCtD
Felodipine—Anaemia—Doxorubicin—ovarian cancer	0.000152	0.00118	CcSEcCtD
Felodipine—Nifedipine—ABCB1—ovarian cancer	0.000151	0.173	CrCbGaD
Felodipine—Arthralgia—Epirubicin—ovarian cancer	0.000151	0.00118	CcSEcCtD
Felodipine—Myalgia—Epirubicin—ovarian cancer	0.000151	0.00118	CcSEcCtD
Felodipine—Chest pain—Epirubicin—ovarian cancer	0.000151	0.00118	CcSEcCtD
Felodipine—Nausea—Paclitaxel—ovarian cancer	0.000151	0.00117	CcSEcCtD
Felodipine—Nicardipine—ABCB1—ovarian cancer	0.000149	0.17	CrCbGaD
Felodipine—Dry mouth—Epirubicin—ovarian cancer	0.000148	0.00115	CcSEcCtD
Felodipine—Vertigo—Doxorubicin—ovarian cancer	0.000148	0.00115	CcSEcCtD
Felodipine—Syncope—Doxorubicin—ovarian cancer	0.000147	0.00115	CcSEcCtD
Felodipine—ABCB1—lymph node—ovarian cancer	0.000147	0.00134	CbGeAlD
Felodipine—Diarrhoea—Docetaxel—ovarian cancer	0.000147	0.00115	CcSEcCtD
Felodipine—Confusional state—Epirubicin—ovarian cancer	0.000146	0.00114	CcSEcCtD
Felodipine—Palpitations—Doxorubicin—ovarian cancer	0.000145	0.00113	CcSEcCtD
Felodipine—Loss of consciousness—Doxorubicin—ovarian cancer	0.000145	0.00113	CcSEcCtD
Felodipine—Cough—Doxorubicin—ovarian cancer	0.000143	0.00112	CcSEcCtD
Felodipine—Shock—Epirubicin—ovarian cancer	0.000143	0.00111	CcSEcCtD
Felodipine—Dizziness—Docetaxel—ovarian cancer	0.000142	0.00111	CcSEcCtD
Felodipine—Tachycardia—Epirubicin—ovarian cancer	0.000142	0.0011	CcSEcCtD
Felodipine—Chest pain—Doxorubicin—ovarian cancer	0.00014	0.00109	CcSEcCtD
Felodipine—Myalgia—Doxorubicin—ovarian cancer	0.00014	0.00109	CcSEcCtD
Felodipine—Arthralgia—Doxorubicin—ovarian cancer	0.00014	0.00109	CcSEcCtD
Felodipine—Dry mouth—Doxorubicin—ovarian cancer	0.000137	0.00107	CcSEcCtD
Felodipine—Vomiting—Docetaxel—ovarian cancer	0.000137	0.00106	CcSEcCtD
Felodipine—Rash—Docetaxel—ovarian cancer	0.000136	0.00106	CcSEcCtD
Felodipine—Dermatitis—Docetaxel—ovarian cancer	0.000135	0.00105	CcSEcCtD
Felodipine—Confusional state—Doxorubicin—ovarian cancer	0.000135	0.00105	CcSEcCtD
Felodipine—Headache—Docetaxel—ovarian cancer	0.000135	0.00105	CcSEcCtD
Felodipine—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000132	0.00103	CcSEcCtD
Felodipine—Shock—Doxorubicin—ovarian cancer	0.000132	0.00103	CcSEcCtD
Felodipine—Insomnia—Epirubicin—ovarian cancer	0.000131	0.00102	CcSEcCtD
Felodipine—Tachycardia—Doxorubicin—ovarian cancer	0.000131	0.00102	CcSEcCtD
Felodipine—Paraesthesia—Epirubicin—ovarian cancer	0.00013	0.00101	CcSEcCtD
Felodipine—Dyspnoea—Epirubicin—ovarian cancer	0.000129	0.00101	CcSEcCtD
Felodipine—Somnolence—Epirubicin—ovarian cancer	0.000129	0.001	CcSEcCtD
Felodipine—Nausea—Docetaxel—ovarian cancer	0.000128	0.000995	CcSEcCtD
Felodipine—Dyspepsia—Epirubicin—ovarian cancer	0.000128	0.000994	CcSEcCtD
Felodipine—Fatigue—Epirubicin—ovarian cancer	0.000125	0.000974	CcSEcCtD
Felodipine—Constipation—Epirubicin—ovarian cancer	0.000124	0.000966	CcSEcCtD
Felodipine—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000122	0.000952	CcSEcCtD
Felodipine—Insomnia—Doxorubicin—ovarian cancer	0.000121	0.000945	CcSEcCtD
Felodipine—Paraesthesia—Doxorubicin—ovarian cancer	0.000121	0.000939	CcSEcCtD
Felodipine—Dyspnoea—Doxorubicin—ovarian cancer	0.00012	0.000932	CcSEcCtD
Felodipine—Feeling abnormal—Epirubicin—ovarian cancer	0.00012	0.000931	CcSEcCtD
Felodipine—Somnolence—Doxorubicin—ovarian cancer	0.000119	0.000929	CcSEcCtD
Felodipine—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000119	0.000924	CcSEcCtD
Felodipine—Dyspepsia—Doxorubicin—ovarian cancer	0.000118	0.00092	CcSEcCtD
Felodipine—Fatigue—Doxorubicin—ovarian cancer	0.000116	0.000901	CcSEcCtD
Felodipine—Urticaria—Epirubicin—ovarian cancer	0.000115	0.000897	CcSEcCtD
Felodipine—Constipation—Doxorubicin—ovarian cancer	0.000115	0.000894	CcSEcCtD
Felodipine—Abdominal pain—Epirubicin—ovarian cancer	0.000115	0.000893	CcSEcCtD
Felodipine—Body temperature increased—Epirubicin—ovarian cancer	0.000115	0.000893	CcSEcCtD
Felodipine—Feeling abnormal—Doxorubicin—ovarian cancer	0.000111	0.000861	CcSEcCtD
Felodipine—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.00011	0.000855	CcSEcCtD
Felodipine—Hypersensitivity—Epirubicin—ovarian cancer	0.000107	0.000832	CcSEcCtD
Felodipine—Urticaria—Doxorubicin—ovarian cancer	0.000107	0.00083	CcSEcCtD
Felodipine—Abdominal pain—Doxorubicin—ovarian cancer	0.000106	0.000826	CcSEcCtD
Felodipine—Body temperature increased—Doxorubicin—ovarian cancer	0.000106	0.000826	CcSEcCtD
Felodipine—Asthenia—Epirubicin—ovarian cancer	0.000104	0.00081	CcSEcCtD
Felodipine—Pruritus—Epirubicin—ovarian cancer	0.000103	0.000799	CcSEcCtD
Felodipine—Diarrhoea—Epirubicin—ovarian cancer	9.92e-05	0.000773	CcSEcCtD
Felodipine—Hypersensitivity—Doxorubicin—ovarian cancer	9.89e-05	0.00077	CcSEcCtD
Felodipine—Asthenia—Doxorubicin—ovarian cancer	9.63e-05	0.00075	CcSEcCtD
Felodipine—Dizziness—Epirubicin—ovarian cancer	9.59e-05	0.000747	CcSEcCtD
Felodipine—Pruritus—Doxorubicin—ovarian cancer	9.49e-05	0.000739	CcSEcCtD
Felodipine—Vomiting—Epirubicin—ovarian cancer	9.22e-05	0.000718	CcSEcCtD
Felodipine—Diarrhoea—Doxorubicin—ovarian cancer	9.18e-05	0.000715	CcSEcCtD
Felodipine—Rash—Epirubicin—ovarian cancer	9.14e-05	0.000712	CcSEcCtD
Felodipine—Dermatitis—Epirubicin—ovarian cancer	9.14e-05	0.000712	CcSEcCtD
Felodipine—Headache—Epirubicin—ovarian cancer	9.09e-05	0.000708	CcSEcCtD
Felodipine—Dizziness—Doxorubicin—ovarian cancer	8.87e-05	0.000691	CcSEcCtD
Felodipine—Nausea—Epirubicin—ovarian cancer	8.61e-05	0.000671	CcSEcCtD
Felodipine—Vomiting—Doxorubicin—ovarian cancer	8.53e-05	0.000665	CcSEcCtD
Felodipine—Rash—Doxorubicin—ovarian cancer	8.46e-05	0.000659	CcSEcCtD
Felodipine—Dermatitis—Doxorubicin—ovarian cancer	8.45e-05	0.000658	CcSEcCtD
Felodipine—Headache—Doxorubicin—ovarian cancer	8.41e-05	0.000655	CcSEcCtD
Felodipine—Nausea—Doxorubicin—ovarian cancer	7.97e-05	0.000621	CcSEcCtD
Felodipine—CALM2—Immune System—CTNNB1—ovarian cancer	5.52e-06	3.27e-05	CbGpPWpGaD
Felodipine—CALM1—Immune System—CTNNB1—ovarian cancer	5.52e-06	3.27e-05	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—SLC5A5—ovarian cancer	5.52e-06	3.27e-05	CbGpPWpGaD
Felodipine—CALM3—Innate Immune System—AKT1—ovarian cancer	5.51e-06	3.26e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—IL6ST—ovarian cancer	5.47e-06	3.24e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—IL6ST—ovarian cancer	5.47e-06	3.24e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—APC—ovarian cancer	5.43e-06	3.22e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—PIK3CG—ovarian cancer	5.43e-06	3.22e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling by GPCR—NRAS—ovarian cancer	5.43e-06	3.22e-05	CbGpPWpGaD
Felodipine—ABCB1—Metabolism—CAV1—ovarian cancer	5.41e-06	3.2e-05	CbGpPWpGaD
Felodipine—CALM2—Disease—CDKN1B—ovarian cancer	5.4e-06	3.19e-05	CbGpPWpGaD
Felodipine—CALM1—Disease—CDKN1B—ovarian cancer	5.4e-06	3.19e-05	CbGpPWpGaD
Felodipine—CALM2—Immune System—PTEN—ovarian cancer	5.38e-06	3.19e-05	CbGpPWpGaD
Felodipine—CALM1—Immune System—PTEN—ovarian cancer	5.38e-06	3.19e-05	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—SLC2A1—ovarian cancer	5.33e-06	3.16e-05	CbGpPWpGaD
Felodipine—CALM2—Innate Immune System—AKT1—ovarian cancer	5.33e-06	3.15e-05	CbGpPWpGaD
Felodipine—CALM1—Innate Immune System—AKT1—ovarian cancer	5.33e-06	3.15e-05	CbGpPWpGaD
Felodipine—CALM3—Adaptive Immune System—AKT1—ovarian cancer	5.29e-06	3.13e-05	CbGpPWpGaD
Felodipine—CALM3—Disease—CTNNB1—ovarian cancer	5.27e-06	3.12e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—PIK3CG—ovarian cancer	5.26e-06	3.11e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—APC—ovarian cancer	5.26e-06	3.11e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—PIK3CG—ovarian cancer	5.26e-06	3.11e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—APC—ovarian cancer	5.26e-06	3.11e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling by GPCR—NRAS—ovarian cancer	5.26e-06	3.11e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling by GPCR—NRAS—ovarian cancer	5.26e-06	3.11e-05	CbGpPWpGaD
Felodipine—PDE1B—Signaling Pathways—AKT1—ovarian cancer	5.23e-06	3.09e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling by GPCR—MAPK3—ovarian cancer	5.2e-06	3.08e-05	CbGpPWpGaD
Felodipine—CALM3—Disease—PTEN—ovarian cancer	5.14e-06	3.04e-05	CbGpPWpGaD
Felodipine—CALM2—Adaptive Immune System—AKT1—ovarian cancer	5.11e-06	3.03e-05	CbGpPWpGaD
Felodipine—CALM1—Adaptive Immune System—AKT1—ovarian cancer	5.11e-06	3.03e-05	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—CYP1B1—ovarian cancer	5.11e-06	3.03e-05	CbGpPWpGaD
Felodipine—CALM2—Disease—CTNNB1—ovarian cancer	5.1e-06	3.02e-05	CbGpPWpGaD
Felodipine—CALM1—Disease—CTNNB1—ovarian cancer	5.1e-06	3.02e-05	CbGpPWpGaD
Felodipine—CYP2D6—Metabolism—CAV1—ovarian cancer	5.09e-06	3.02e-05	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism—CAV1—ovarian cancer	5.05e-06	2.99e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling by GPCR—MAPK3—ovarian cancer	5.03e-06	2.98e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling by GPCR—MAPK3—ovarian cancer	5.03e-06	2.98e-05	CbGpPWpGaD
Felodipine—CYP3A5—Metabolism—PIK3CB—ovarian cancer	5e-06	2.96e-05	CbGpPWpGaD
Felodipine—CALM3—Metabolism—PIK3CB—ovarian cancer	4.98e-06	2.95e-05	CbGpPWpGaD
Felodipine—CALM3—Immune System—STAT3—ovarian cancer	4.98e-06	2.95e-05	CbGpPWpGaD
Felodipine—CALM2—Disease—PTEN—ovarian cancer	4.97e-06	2.94e-05	CbGpPWpGaD
Felodipine—CALM1—Disease—PTEN—ovarian cancer	4.97e-06	2.94e-05	CbGpPWpGaD
Felodipine—CYP2C8—Metabolism—PIK3CD—ovarian cancer	4.97e-06	2.94e-05	CbGpPWpGaD
Felodipine—CALM3—Immune System—NRAS—ovarian cancer	4.96e-06	2.94e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling by GPCR—MAPK1—ovarian cancer	4.95e-06	2.93e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling by GPCR—EGFR—ovarian cancer	4.95e-06	2.93e-05	CbGpPWpGaD
Felodipine—ABCB1—Metabolism—PIK3CG—ovarian cancer	4.92e-06	2.91e-05	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.83e-06	2.86e-05	CbGpPWpGaD
Felodipine—CALM1—Metabolism—PIK3CB—ovarian cancer	4.82e-06	2.85e-05	CbGpPWpGaD
Felodipine—CALM2—Metabolism—PIK3CB—ovarian cancer	4.82e-06	2.85e-05	CbGpPWpGaD
Felodipine—CALM2—Immune System—STAT3—ovarian cancer	4.81e-06	2.85e-05	CbGpPWpGaD
Felodipine—CALM1—Immune System—STAT3—ovarian cancer	4.81e-06	2.85e-05	CbGpPWpGaD
Felodipine—CALM2—Immune System—NRAS—ovarian cancer	4.8e-06	2.84e-05	CbGpPWpGaD
Felodipine—CALM1—Immune System—NRAS—ovarian cancer	4.8e-06	2.84e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling by GPCR—MAPK1—ovarian cancer	4.79e-06	2.83e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling by GPCR—MAPK1—ovarian cancer	4.79e-06	2.83e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling by GPCR—EGFR—ovarian cancer	4.79e-06	2.83e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling by GPCR—EGFR—ovarian cancer	4.79e-06	2.83e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—PIK3CD—ovarian cancer	4.78e-06	2.83e-05	CbGpPWpGaD
Felodipine—CALM3—Immune System—MAPK3—ovarian cancer	4.75e-06	2.81e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling by GPCR—KRAS—ovarian cancer	4.68e-06	2.77e-05	CbGpPWpGaD
Felodipine—CYP2D6—Metabolism—PIK3CG—ovarian cancer	4.64e-06	2.75e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—PIK3CD—ovarian cancer	4.62e-06	2.73e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—PIK3CD—ovarian cancer	4.62e-06	2.73e-05	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism—PIK3CG—ovarian cancer	4.6e-06	2.72e-05	CbGpPWpGaD
Felodipine—CALM1—Immune System—MAPK3—ovarian cancer	4.6e-06	2.72e-05	CbGpPWpGaD
Felodipine—CALM2—Immune System—MAPK3—ovarian cancer	4.6e-06	2.72e-05	CbGpPWpGaD
Felodipine—CALM3—Disease—STAT3—ovarian cancer	4.59e-06	2.72e-05	CbGpPWpGaD
Felodipine—CALM3—Disease—NRAS—ovarian cancer	4.58e-06	2.71e-05	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	4.53e-06	2.68e-05	CbGpPWpGaD
Felodipine—CALM3—Immune System—MAPK1—ovarian cancer	4.52e-06	2.68e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling by GPCR—KRAS—ovarian cancer	4.52e-06	2.68e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling by GPCR—KRAS—ovarian cancer	4.52e-06	2.68e-05	CbGpPWpGaD
Felodipine—CALM3—Immune System—EGFR—ovarian cancer	4.52e-06	2.68e-05	CbGpPWpGaD
Felodipine—CALM1—Disease—STAT3—ovarian cancer	4.44e-06	2.63e-05	CbGpPWpGaD
Felodipine—CALM2—Disease—STAT3—ovarian cancer	4.44e-06	2.63e-05	CbGpPWpGaD
Felodipine—CALM1—Disease—NRAS—ovarian cancer	4.43e-06	2.62e-05	CbGpPWpGaD
Felodipine—CALM2—Disease—NRAS—ovarian cancer	4.43e-06	2.62e-05	CbGpPWpGaD
Felodipine—CALM3—Disease—MAPK3—ovarian cancer	4.39e-06	2.6e-05	CbGpPWpGaD
Felodipine—CALM1—Immune System—MAPK1—ovarian cancer	4.38e-06	2.59e-05	CbGpPWpGaD
Felodipine—CALM2—Immune System—MAPK1—ovarian cancer	4.38e-06	2.59e-05	CbGpPWpGaD
Felodipine—CALM1—Immune System—EGFR—ovarian cancer	4.38e-06	2.59e-05	CbGpPWpGaD
Felodipine—CALM2—Immune System—EGFR—ovarian cancer	4.38e-06	2.59e-05	CbGpPWpGaD
Felodipine—CYP2C8—Metabolism—PIK3CB—ovarian cancer	4.33e-06	2.56e-05	CbGpPWpGaD
Felodipine—ABCB1—Metabolism—PIK3CD—ovarian cancer	4.33e-06	2.56e-05	CbGpPWpGaD
Felodipine—CYP3A5—Metabolism—PTEN—ovarian cancer	4.32e-06	2.56e-05	CbGpPWpGaD
Felodipine—CALM3—Metabolism—PTEN—ovarian cancer	4.3e-06	2.55e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling by GPCR—PIK3CA—ovarian cancer	4.3e-06	2.54e-05	CbGpPWpGaD
Felodipine—CALM3—Immune System—KRAS—ovarian cancer	4.27e-06	2.53e-05	CbGpPWpGaD
Felodipine—CALM3—Disease—MYC—ovarian cancer	4.27e-06	2.53e-05	CbGpPWpGaD
Felodipine—CALM2—Disease—MAPK3—ovarian cancer	4.25e-06	2.51e-05	CbGpPWpGaD
Felodipine—CALM1—Disease—MAPK3—ovarian cancer	4.25e-06	2.51e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—ERBB2—ovarian cancer	4.22e-06	2.5e-05	CbGpPWpGaD
Felodipine—CYP3A7—Metabolism—PIK3CA—ovarian cancer	4.22e-06	2.5e-05	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—ABCB1—ovarian cancer	4.21e-06	2.49e-05	CbGpPWpGaD
Felodipine—CALM3—Disease—MAPK1—ovarian cancer	4.18e-06	2.47e-05	CbGpPWpGaD
Felodipine—CALM3—Disease—EGFR—ovarian cancer	4.18e-06	2.47e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—PIK3CB—ovarian cancer	4.16e-06	2.46e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—MTOR—ovarian cancer	4.16e-06	2.46e-05	CbGpPWpGaD
Felodipine—CALM1—Metabolism—PTEN—ovarian cancer	4.16e-06	2.46e-05	CbGpPWpGaD
Felodipine—CALM2—Metabolism—PTEN—ovarian cancer	4.16e-06	2.46e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling by GPCR—PIK3CA—ovarian cancer	4.16e-06	2.46e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling by GPCR—PIK3CA—ovarian cancer	4.16e-06	2.46e-05	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—TYMS—ovarian cancer	4.13e-06	2.45e-05	CbGpPWpGaD
Felodipine—CALM2—Immune System—KRAS—ovarian cancer	4.13e-06	2.45e-05	CbGpPWpGaD
Felodipine—CALM1—Immune System—KRAS—ovarian cancer	4.13e-06	2.45e-05	CbGpPWpGaD
Felodipine—CALM1—Disease—MYC—ovarian cancer	4.13e-06	2.44e-05	CbGpPWpGaD
Felodipine—CALM2—Disease—MYC—ovarian cancer	4.13e-06	2.44e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—ERBB2—ovarian cancer	4.08e-06	2.42e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—ERBB2—ovarian cancer	4.08e-06	2.42e-05	CbGpPWpGaD
Felodipine—CYP2D6—Metabolism—PIK3CD—ovarian cancer	4.08e-06	2.41e-05	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism—PIK3CD—ovarian cancer	4.04e-06	2.39e-05	CbGpPWpGaD
Felodipine—CALM2—Disease—MAPK1—ovarian cancer	4.04e-06	2.39e-05	CbGpPWpGaD
Felodipine—CALM1—Disease—MAPK1—ovarian cancer	4.04e-06	2.39e-05	CbGpPWpGaD
Felodipine—CALM1—Disease—EGFR—ovarian cancer	4.04e-06	2.39e-05	CbGpPWpGaD
Felodipine—CALM2—Disease—EGFR—ovarian cancer	4.04e-06	2.39e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—PIK3CB—ovarian cancer	4.03e-06	2.38e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—MTOR—ovarian cancer	4.03e-06	2.38e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—PIK3CB—ovarian cancer	4.03e-06	2.38e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—MTOR—ovarian cancer	4.03e-06	2.38e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—CXCL8—ovarian cancer	4e-06	2.37e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling by GPCR—HRAS—ovarian cancer	3.97e-06	2.35e-05	CbGpPWpGaD
Felodipine—CALM3—Disease—KRAS—ovarian cancer	3.94e-06	2.33e-05	CbGpPWpGaD
Felodipine—CALM3—Immune System—PIK3CA—ovarian cancer	3.93e-06	2.32e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—CDKN1B—ovarian cancer	3.91e-06	2.31e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—CXCL8—ovarian cancer	3.87e-06	2.29e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—CXCL8—ovarian cancer	3.87e-06	2.29e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling by GPCR—HRAS—ovarian cancer	3.84e-06	2.28e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling by GPCR—HRAS—ovarian cancer	3.84e-06	2.28e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—CASP3—ovarian cancer	3.83e-06	2.27e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—IL2—ovarian cancer	3.82e-06	2.26e-05	CbGpPWpGaD
Felodipine—CALM1—Disease—KRAS—ovarian cancer	3.82e-06	2.26e-05	CbGpPWpGaD
Felodipine—CALM2—Disease—KRAS—ovarian cancer	3.82e-06	2.26e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling by GPCR—IL6—ovarian cancer	3.8e-06	2.25e-05	CbGpPWpGaD
Felodipine—CALM1—Immune System—PIK3CA—ovarian cancer	3.8e-06	2.25e-05	CbGpPWpGaD
Felodipine—CALM2—Immune System—PIK3CA—ovarian cancer	3.8e-06	2.25e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—CDKN1B—ovarian cancer	3.78e-06	2.24e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—CDKN1B—ovarian cancer	3.78e-06	2.24e-05	CbGpPWpGaD
Felodipine—ABCB1—Metabolism—PIK3CB—ovarian cancer	3.77e-06	2.23e-05	CbGpPWpGaD
Felodipine—CYP2C8—Metabolism—PTEN—ovarian cancer	3.74e-06	2.22e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—CCND1—ovarian cancer	3.73e-06	2.21e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—CASP3—ovarian cancer	3.7e-06	2.19e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—CASP3—ovarian cancer	3.7e-06	2.19e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—IL2—ovarian cancer	3.7e-06	2.19e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—IL2—ovarian cancer	3.7e-06	2.19e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—CTNNB1—ovarian cancer	3.69e-06	2.18e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling by GPCR—IL6—ovarian cancer	3.68e-06	2.18e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling by GPCR—IL6—ovarian cancer	3.68e-06	2.18e-05	CbGpPWpGaD
Felodipine—CALM3—Immune System—HRAS—ovarian cancer	3.63e-06	2.15e-05	CbGpPWpGaD
Felodipine—CALM3—Disease—PIK3CA—ovarian cancer	3.62e-06	2.15e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—MMP9—ovarian cancer	3.62e-06	2.14e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—CCND1—ovarian cancer	3.61e-06	2.13e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—CCND1—ovarian cancer	3.61e-06	2.13e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—PTEN—ovarian cancer	3.6e-06	2.13e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—CTNNB1—ovarian cancer	3.57e-06	2.11e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—CTNNB1—ovarian cancer	3.57e-06	2.11e-05	CbGpPWpGaD
Felodipine—CYP2D6—Metabolism—PIK3CB—ovarian cancer	3.56e-06	2.1e-05	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism—PIK3CB—ovarian cancer	3.52e-06	2.09e-05	CbGpPWpGaD
Felodipine—CALM1—Immune System—HRAS—ovarian cancer	3.51e-06	2.08e-05	CbGpPWpGaD
Felodipine—CALM2—Immune System—HRAS—ovarian cancer	3.51e-06	2.08e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling by GPCR—AKT1—ovarian cancer	3.51e-06	2.08e-05	CbGpPWpGaD
Felodipine—CALM2—Disease—PIK3CA—ovarian cancer	3.51e-06	2.08e-05	CbGpPWpGaD
Felodipine—CALM1—Disease—PIK3CA—ovarian cancer	3.51e-06	2.08e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—MMP9—ovarian cancer	3.5e-06	2.07e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—MMP9—ovarian cancer	3.5e-06	2.07e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—PTEN—ovarian cancer	3.48e-06	2.06e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—PTEN—ovarian cancer	3.48e-06	2.06e-05	CbGpPWpGaD
Felodipine—CALM3—Immune System—IL6—ovarian cancer	3.48e-06	2.06e-05	CbGpPWpGaD
Felodipine—CYP3A7—Metabolism—AKT1—ovarian cancer	3.44e-06	2.04e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling by GPCR—AKT1—ovarian cancer	3.4e-06	2.01e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling by GPCR—AKT1—ovarian cancer	3.4e-06	2.01e-05	CbGpPWpGaD
Felodipine—CALM2—Immune System—IL6—ovarian cancer	3.36e-06	1.99e-05	CbGpPWpGaD
Felodipine—CALM1—Immune System—IL6—ovarian cancer	3.36e-06	1.99e-05	CbGpPWpGaD
Felodipine—CALM3—Disease—HRAS—ovarian cancer	3.35e-06	1.98e-05	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—CAV1—ovarian cancer	3.33e-06	1.97e-05	CbGpPWpGaD
Felodipine—ABCB1—Metabolism—PTEN—ovarian cancer	3.26e-06	1.93e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—VEGFA—ovarian cancer	3.25e-06	1.92e-05	CbGpPWpGaD
Felodipine—CALM1—Disease—HRAS—ovarian cancer	3.24e-06	1.92e-05	CbGpPWpGaD
Felodipine—CALM2—Disease—HRAS—ovarian cancer	3.24e-06	1.92e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—STAT3—ovarian cancer	3.22e-06	1.9e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—NRAS—ovarian cancer	3.21e-06	1.9e-05	CbGpPWpGaD
Felodipine—CALM3—Disease—IL6—ovarian cancer	3.21e-06	1.9e-05	CbGpPWpGaD
Felodipine—CALM3—Immune System—AKT1—ovarian cancer	3.21e-06	1.9e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—VEGFA—ovarian cancer	3.14e-06	1.86e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—VEGFA—ovarian cancer	3.14e-06	1.86e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—STAT3—ovarian cancer	3.11e-06	1.84e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—STAT3—ovarian cancer	3.11e-06	1.84e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—NRAS—ovarian cancer	3.1e-06	1.84e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—NRAS—ovarian cancer	3.1e-06	1.84e-05	CbGpPWpGaD
Felodipine—CALM1—Disease—IL6—ovarian cancer	3.1e-06	1.84e-05	CbGpPWpGaD
Felodipine—CALM2—Disease—IL6—ovarian cancer	3.1e-06	1.84e-05	CbGpPWpGaD
Felodipine—CALM2—Immune System—AKT1—ovarian cancer	3.1e-06	1.84e-05	CbGpPWpGaD
Felodipine—CALM1—Immune System—AKT1—ovarian cancer	3.1e-06	1.84e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—MAPK3—ovarian cancer	3.07e-06	1.82e-05	CbGpPWpGaD
Felodipine—CYP2D6—Metabolism—PTEN—ovarian cancer	3.07e-06	1.82e-05	CbGpPWpGaD
Felodipine—CYP3A5—Metabolism—PIK3CA—ovarian cancer	3.05e-06	1.8e-05	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism—PTEN—ovarian cancer	3.05e-06	1.8e-05	CbGpPWpGaD
Felodipine—CALM3—Metabolism—PIK3CA—ovarian cancer	3.04e-06	1.8e-05	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—PIK3CG—ovarian cancer	3.03e-06	1.8e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—MYC—ovarian cancer	2.99e-06	1.77e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—MAPK3—ovarian cancer	2.97e-06	1.76e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—MAPK3—ovarian cancer	2.97e-06	1.76e-05	CbGpPWpGaD
Felodipine—CALM3—Disease—AKT1—ovarian cancer	2.96e-06	1.75e-05	CbGpPWpGaD
Felodipine—CALM2—Metabolism—PIK3CA—ovarian cancer	2.94e-06	1.74e-05	CbGpPWpGaD
Felodipine—CALM1—Metabolism—PIK3CA—ovarian cancer	2.94e-06	1.74e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—MAPK1—ovarian cancer	2.92e-06	1.73e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—EGFR—ovarian cancer	2.92e-06	1.73e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—MYC—ovarian cancer	2.89e-06	1.71e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—MYC—ovarian cancer	2.89e-06	1.71e-05	CbGpPWpGaD
Felodipine—CALM1—Disease—AKT1—ovarian cancer	2.86e-06	1.7e-05	CbGpPWpGaD
Felodipine—CALM2—Disease—AKT1—ovarian cancer	2.86e-06	1.7e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—MAPK1—ovarian cancer	2.83e-06	1.67e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—MAPK1—ovarian cancer	2.83e-06	1.67e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—EGFR—ovarian cancer	2.83e-06	1.67e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—EGFR—ovarian cancer	2.83e-06	1.67e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—KRAS—ovarian cancer	2.76e-06	1.63e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—KRAS—ovarian cancer	2.67e-06	1.58e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—KRAS—ovarian cancer	2.67e-06	1.58e-05	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—PIK3CD—ovarian cancer	2.67e-06	1.58e-05	CbGpPWpGaD
Felodipine—CYP2C8—Metabolism—PIK3CA—ovarian cancer	2.64e-06	1.56e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—PIK3CA—ovarian cancer	2.54e-06	1.5e-05	CbGpPWpGaD
Felodipine—CYP3A5—Metabolism—AKT1—ovarian cancer	2.49e-06	1.47e-05	CbGpPWpGaD
Felodipine—CALM3—Metabolism—AKT1—ovarian cancer	2.48e-06	1.47e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—TP53—ovarian cancer	2.46e-06	1.45e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—PIK3CA—ovarian cancer	2.46e-06	1.45e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—PIK3CA—ovarian cancer	2.46e-06	1.45e-05	CbGpPWpGaD
Felodipine—CALM2—Metabolism—AKT1—ovarian cancer	2.4e-06	1.42e-05	CbGpPWpGaD
Felodipine—CALM1—Metabolism—AKT1—ovarian cancer	2.4e-06	1.42e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—TP53—ovarian cancer	2.38e-06	1.41e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—TP53—ovarian cancer	2.38e-06	1.41e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—HRAS—ovarian cancer	2.35e-06	1.39e-05	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—PIK3CB—ovarian cancer	2.32e-06	1.38e-05	CbGpPWpGaD
Felodipine—ABCB1—Metabolism—PIK3CA—ovarian cancer	2.3e-06	1.36e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—HRAS—ovarian cancer	2.27e-06	1.34e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—HRAS—ovarian cancer	2.27e-06	1.34e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—IL6—ovarian cancer	2.25e-06	1.33e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—IL6—ovarian cancer	2.17e-06	1.29e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—IL6—ovarian cancer	2.17e-06	1.29e-05	CbGpPWpGaD
Felodipine—CYP2D6—Metabolism—PIK3CA—ovarian cancer	2.17e-06	1.28e-05	CbGpPWpGaD
Felodipine—CYP2C8—Metabolism—AKT1—ovarian cancer	2.16e-06	1.28e-05	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism—PIK3CA—ovarian cancer	2.15e-06	1.27e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—AKT1—ovarian cancer	2.07e-06	1.23e-05	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—PTEN—ovarian cancer	2.01e-06	1.19e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—AKT1—ovarian cancer	2.01e-06	1.19e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—AKT1—ovarian cancer	2.01e-06	1.19e-05	CbGpPWpGaD
Felodipine—ABCB1—Metabolism—AKT1—ovarian cancer	1.88e-06	1.11e-05	CbGpPWpGaD
Felodipine—CYP2D6—Metabolism—AKT1—ovarian cancer	1.77e-06	1.05e-05	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism—AKT1—ovarian cancer	1.76e-06	1.04e-05	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.42e-06	8.39e-06	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—AKT1—ovarian cancer	1.16e-06	6.85e-06	CbGpPWpGaD
